CINA CHEST vs HeartFlow Analysis
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for life-threatening acute chest conditions like Pulmonary Embolism and Aortic Dissection in an emergency setting. This tool is ideal for assisting radiologists and emergency departments in quickly identifying and prioritizing critical cases from CT angiography scans to optimize workflow.
View CINA CHEST →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, AI-driven solution for the comprehensive diagnosis and management of coronary artery disease (CAD). This tool excels at creating personalized 3D models of coronary arteries from standard CT scans, providing detailed FFRct and plaque analysis to guide treatment decisions for stable patients.
View HeartFlow Analysis →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | HeartFlow Analysis |
|---|---|---|
| Pricing | Subscription-based | Contact vendor for pricing |
| Deployment | Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | K210237 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CINA CHESTCINA CHEST operates as a standalone web application and focuses on rapid triage and notification, suggesting a streamlined and intuitive user experience for immediate alerts. HeartFlow Analysis, while powerful, involves detailed 3D modeling and computational fluid dynamics, which may imply a more complex interface and potentially a steeper learning curve for comprehensive analysis.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis has an extensive body of clinical evidence, including large-scale real-world studies (e.g., FISH&CHIPS with over 90,000 patients) and numerous randomized controlled trials, demonstrating its ability to improve diagnostic accuracy, reduce invasive procedures, enhance patient outcomes, and deliver cost savings. While CINA CHEST has published studies validating its accuracy for PE and AD detection and its impact on workflow efficiency, HeartFlow's evidence base appears more comprehensive in demonstrating a broader impact on patient management pathways and healthcare economics.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis operates on a fee-for-service model with established Category I CPT codes (75580, 75577 for 2026) and is covered by Medicare and most U.S. commercial payers, providing clear and transparent reimbursement pathways for healthcare providers. CINA CHEST uses a subscription-based model with details available upon request, which offers less immediate transparency regarding its financial value proposition.
Enterprise Readiness
CINA CHESTCINA CHEST offers more flexible deployment options, including cloud-based, on-premise (dedicated hardware), and virtualized (VM, Docker) solutions, which can cater to diverse IT infrastructures and security requirements within large enterprise healthcare systems. HeartFlow Analysis is primarily cloud-based (AWS), which may be less adaptable for organizations with strict on-premise mandates or specific cloud provider preferences.
Innovation
HeartFlow AnalysisHeartFlow Analysis demonstrates a higher degree of innovation by combining AI with advanced computational fluid dynamics to non-invasively derive Fractional Flow Reserve from CT (FFRct), a measure traditionally requiring invasive catheterization. This represents a significant paradigm shift in non-invasive functional assessment for coronary artery disease. CINA CHEST's innovation lies in rapid AI-powered triage for acute conditions, which is valuable but less of a methodological breakthrough compared to HeartFlow's approach.
Support & Docs
TieNeither the provided structured facts nor readily available web search results offer specific comparative details on the quality, accessibility, or comprehensiveness of support services and documentation for either CINA CHEST or HeartFlow Analysis. Therefore, it is not possible to definitively pick a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | HeartFlow Analysis |
|---|---|---|
| Name | CINA CHEST | HeartFlow Analysis |
| Company | Avicenna.AI | HeartFlow |
| Description | FDA-cleared AI-powered radiological triage and notification software by Avicenna.AI, designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Primary Use Case | Radiological triage and notification for Pulmonary Embolism (PE) and Aortic Dissection (AD) | Non-invasive diagnosis and management of coronary artery disease (CAD) |
| Key Features (Examples) | Detection of Pulmonary Embolism (PE) on Chest CT angiography, Detection of Aortic Dissection (AD) on Chest or Thoraco-abdominal CT angiography, Flags and communicates suspected positive findings | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization) |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and HeartFlow Analysis.